PT1143954E - Utilizacao de derivados de acido nocotinico para o tratamento de danos no adn em celulas da pele - Google Patents

Utilizacao de derivados de acido nocotinico para o tratamento de danos no adn em celulas da pele

Info

Publication number
PT1143954E
PT1143954E PT99962960T PT99962960T PT1143954E PT 1143954 E PT1143954 E PT 1143954E PT 99962960 T PT99962960 T PT 99962960T PT 99962960 T PT99962960 T PT 99962960T PT 1143954 E PT1143954 E PT 1143954E
Authority
PT
Portugal
Prior art keywords
nocotinic
treatment
acid derivatives
dna damage
skin cells
Prior art date
Application number
PT99962960T
Other languages
English (en)
Inventor
Elaine L Jacobson
Myron K Jacobson
Original Assignee
Univ Kentucky Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22333250&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1143954(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Kentucky Res Found filed Critical Univ Kentucky Res Found
Publication of PT1143954E publication Critical patent/PT1143954E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
PT99962960T 1998-12-01 1999-12-01 Utilizacao de derivados de acido nocotinico para o tratamento de danos no adn em celulas da pele PT1143954E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11048298P 1998-12-01 1998-12-01

Publications (1)

Publication Number Publication Date
PT1143954E true PT1143954E (pt) 2004-12-31

Family

ID=22333250

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99962960T PT1143954E (pt) 1998-12-01 1999-12-01 Utilizacao de derivados de acido nocotinico para o tratamento de danos no adn em celulas da pele

Country Status (15)

Country Link
US (4) US6337065B1 (pt)
EP (1) EP1143954B1 (pt)
AR (1) AR023715A1 (pt)
AT (1) ATE273008T1 (pt)
AU (1) AU762770B2 (pt)
CA (1) CA2352964C (pt)
DE (1) DE69919403T2 (pt)
DK (1) DK1143954T3 (pt)
ES (1) ES2228146T3 (pt)
HK (1) HK1041436B (pt)
IL (2) IL143112A0 (pt)
NZ (1) NZ511708A (pt)
PT (1) PT1143954E (pt)
TW (1) TWI257303B (pt)
WO (1) WO2000032179A2 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032179A2 (en) * 1998-12-01 2000-06-08 University Of Kentucky Research Foundation Use of nicotonic acid derivatives for the treatment of dna damage in skin cells
US6864274B2 (en) 1999-07-23 2005-03-08 Alwyn Company, Inc. Allantoin-containing skin cream
US6531500B2 (en) 1999-07-23 2003-03-11 Alwyn Company, Inc. Methods for treatment of inflammatory diseases
US6896897B2 (en) 1999-07-23 2005-05-24 Alwyn Company, Inc. Flexible applicator for applying oil-in-water emulsion with improved stability
US6673826B2 (en) 1999-07-23 2004-01-06 Alwyn Company, Inc. Methods for treatment of inflammatory diseases
US20020054895A1 (en) 1999-07-23 2002-05-09 Alwyn Company, Inc. Allantoin-containing skin cream
PT1272183E (pt) * 2000-04-14 2007-01-31 Niadyne Corp Métodos e composições úteis para aumentar o fornecimento de oxigénio às células
MXPA02010184A (es) * 2000-04-14 2004-08-19 Niadyne Corp Formulaciones topicas para el suministro transdermico de niacina y metodos para tratar hiperlipidemia.
US20020182585A1 (en) * 2001-01-10 2002-12-05 George Kindness Combination and method using EDTA, cystine, zinc and selenium for anti-thrombin effect and for anti-platelet aggregation and measurement of efficacy
CA2437844C (en) * 2001-03-08 2007-05-15 Elaine Jacobson Method for increasing leptin levels using nicotinic acid compounds
ITMI20011019A1 (it) * 2001-05-17 2002-11-17 Carlo Ghisalberti Sostanze furiliche per uso topico
AU2002950744A0 (en) * 2002-08-13 2002-09-12 Medihoney Pty Ltd Composition
US7326690B2 (en) * 2002-10-30 2008-02-05 Bach Pharma, Inc. Modulation of cell fates and activities by phthalazinediones
KR20050089827A (ko) * 2002-12-19 2005-09-08 이츠차크 힐만 항균성 펩티드 억제물을 통한 질환 치료
KR20050089857A (ko) * 2002-12-26 2005-09-08 아지노모토 가부시키가이샤 간암 발생 및 진행 억제제
US20040161435A1 (en) * 2003-02-14 2004-08-19 Gupta Shyam K. Skin Firming Anti-Aging Cosmetic Mask Compositions
JP4299299B2 (ja) 2003-05-19 2009-07-22 株式会社ジーンケア研究所 癌細胞に対するアポトーシス誘導剤
US8338648B2 (en) * 2004-06-12 2012-12-25 Signum Biosciences, Inc. Topical compositions and methods for epithelial-related conditions
US7615641B2 (en) * 2004-07-20 2009-11-10 Sino Pharmaceuticals Corporation Long chain aliphatic alcohol derivatives and methods of making and using same
CA2612235C (en) 2005-06-24 2013-10-22 Arizona Board Of Regents On Behalf Of The University Of Arizona Method for treating hair growth disorders, such as female pattern alopecia, and compositions useful therefor
WO2007136744A1 (en) * 2006-05-19 2007-11-29 The Johns Hopkins University Crystal structure of a substrate complex of nampt/pbef/visfatin
US20070293458A1 (en) * 2006-06-16 2007-12-20 Ip-6 Research Inc. Prevention of nuclear, solar, and other radiation-induced tissue damage
WO2008025755A1 (de) * 2006-09-01 2008-03-06 Basf Se Verwendung von n-haltigen heterozyklen in dermokosmetika
US8754194B2 (en) * 2006-12-22 2014-06-17 Csl Behring Gmbh Modified coagulation factors with prolonged in vivo half-life
WO2008106177A2 (en) * 2007-02-28 2008-09-04 University Of Kentucky Research Foundation Method for alleviating side effects of retinoic acid therapy and/or improving efficacy without interfering with efficacy
US8815936B2 (en) * 2008-03-03 2014-08-26 Nad Life Pty Ltd Pharmaceutical formulations of resveratrol and methods of use thereof for treating cell disorders
EP2168574A1 (en) 2008-09-25 2010-03-31 Noureddine Frid Compound for local deletion of tumors
US8173446B2 (en) 2009-12-21 2012-05-08 General Electric Company Method of producing an integrated micromagnet sensor assembly
US20140135372A1 (en) 2010-02-02 2014-05-15 Elliott Farber Compositions and methods of treatment of inflammatory skin conditions using allantoin
WO2012114204A2 (en) 2011-02-15 2012-08-30 Ecole Polytechnique Federale De Lausanne (Epfl) Epfl-Tto Methods of treating mitochondrial dysfunction
JP6559713B2 (ja) 2014-06-06 2019-08-14 グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited ニコチンアミドリボシド類似体ならびにその医薬組成物および使用
WO2016178207A1 (en) * 2015-05-04 2016-11-10 Ramot At Tel-Aviv University Ltd. Methods and kits for fragmenting dna
US10722465B1 (en) 2017-12-08 2020-07-28 Quicksilber Scientific, Inc. Transparent colloidal vitamin supplement
US11344497B1 (en) 2017-12-08 2022-05-31 Quicksilver Scientific, Inc. Mitochondrial performance enhancement nanoemulsion
CN112955115B (zh) 2018-11-02 2023-06-30 联合利华知识产权控股有限公司 生物能烟酸甘油酯、组合物和使用其的方法
US11291702B1 (en) 2019-04-15 2022-04-05 Quicksilver Scientific, Inc. Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3185679A (en) 1965-05-25 Azepine derivatives
US3276960A (en) 1961-08-21 1966-10-04 Kendall & Co Analgesic methods and compositions
US4246285A (en) 1975-10-20 1981-01-20 The Procter & Gamble Company Skin conditioning compositions containing guanidine inorganic salts
HU184626B (en) 1979-06-01 1984-09-28 Ferrokemia Ipari Congesting cosmetics first of all hair-restorers
DE3174885D1 (en) 1981-02-03 1986-07-31 Ici Plc Process for the extraction of metal values and novel metal extractants
US4607101A (en) 1981-08-27 1986-08-19 Jaye-Boern Laboratories, Inc. Method of treating acne vulgaris with a composition containing carbamide peroxide
US5635497A (en) 1982-06-23 1997-06-03 Yamanouchi Europe B.V. Topical application compositions
US4459153A (en) 1982-09-20 1984-07-10 The United States Of America As Represented By The United States Department Of Energy Pyrochemical process for extracting plutonium from an electrolyte salt
US4474753A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Topical drug delivery system utilizing thermosetting gels
ATE55905T1 (de) 1984-03-07 1990-09-15 Roshdy Ismail Mittel zur behandlung und zum schutz der haut.
US4665192A (en) 1984-03-19 1987-05-12 The Rockefeller University 2-(2-furoyl)-4(5)-2(furanyl)-1H-imidazole
US4758583A (en) 1984-03-19 1988-07-19 The Rockefeller University Method and agents for inhibiting protein aging
EP0182635B1 (en) 1984-11-15 1989-05-31 Nitto Denko Corporation Composition for percutaneous administration
US5053396A (en) * 1985-08-27 1991-10-01 Blass David H Therapeutic composition
DE3532562A1 (de) 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
LU86574A1 (fr) 1986-09-08 1988-04-05 Oreal Composition pour induire et stimuler la croissance des cheveux et freiner leur chute,a base d'esters nicotiniques et de derives de pyrimidine
GB2216003B (en) 1988-02-18 1992-06-10 Toyama Chemical Co Ltd Hair restorer
US4981681A (en) 1988-08-26 1991-01-01 Vittorio Tosti Lotion mixture and method of treating psoriasis
US5077313A (en) 1988-11-25 1991-12-31 Gert Lubec Process for inhibiting pathological collagen cross-linking in diabetes patients
US5133958A (en) 1989-04-20 1992-07-28 Erwin Stuckler Agent for nail, skin and hair care
US5129360A (en) 1990-01-24 1992-07-14 The United States Of America As Represented By The Secretary Of The Air Force Actively cooled effusion cell for chemical vapor deposition
GB9006785D0 (en) 1990-03-27 1990-05-23 Leung Lit Hung Composition and methods for treatment of acne vulgaris and retardation of ageing
US5114957A (en) 1990-05-08 1992-05-19 Biodor U.S. Holding Tocopherol-based antiviral agents and method of using same
US5043162A (en) 1990-09-05 1991-08-27 Trager Seymour F Hair growth promoter
FR2668366B1 (fr) * 1990-10-30 1993-01-29 Oreal Utilisation cosmetique d'une composition ayant une activite antierythemale et composition correspondante.
GB9114346D0 (en) 1991-07-03 1991-08-21 Dow Corning Sa A method of accelerating drug permeation
US5358969A (en) 1991-12-16 1994-10-25 Washington University Method of inhibiting nitric oxide formation
US5240945A (en) 1992-02-18 1993-08-31 Warshaw Thelma G Method and compositions for treating acne
US5318960A (en) 1992-06-03 1994-06-07 Frank Toppo System for transdermal delivery of pain relieving substances
US5449688A (en) 1993-03-30 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Method of treating chronic inflammatory diseases
US6231852B1 (en) * 1993-11-18 2001-05-15 The Regents Of The University Of California Method for reducing BCL-2 expressing cells resistance to death
FR2715565B1 (fr) 1994-01-31 1996-03-15 Oreal Composition cosmétique ou dermatologique stabilisée contenant plusieurs précurseurs d'un même actif pour maximaliser sa libération, son utilisation.
GB9404485D0 (en) 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
DE69420746T2 (de) * 1994-06-02 2000-06-29 Dan Riga Arzneimittel gegen stress, beeinträchtigung und altwerden und verfahren zu ihrer herstellung
US5612382A (en) 1994-07-15 1997-03-18 Frances B. Fike Composition for percutaneous absorption of pharmaceutically active ingredients
US5496827A (en) * 1994-07-15 1996-03-05 Patrick; Jay Compositions for the transdermal delivery of nutrients
DE4433130C2 (de) 1994-09-16 1997-02-06 Deutsches Krebsforsch Poly(ADP-Ribose)-Polymerase überexprimierende tierische Zellinien und Verfahren zur Identifizierung von DNA-schädigenden Substanzen
DE69533714T2 (de) 1994-12-20 2005-03-24 Unilever N.V. Lactat-dehydrogenase Inhibitoren in kosmetischen Mitteln
US5690944A (en) 1994-12-20 1997-11-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing lactate dehydrogenase inhibitors
WO1996028167A1 (en) * 1995-03-14 1996-09-19 Shaskan Edward G Compositions comprising nicotynylalanine and an inhibitor of glycine conjugation or vitamin b6
ATE272055T1 (de) 1995-05-01 2004-08-15 Scarista Ltd Nicotinsäureester und diese enthaltende pharmazeutischen zusammensetzungen
JPH08301760A (ja) * 1995-05-10 1996-11-19 Shiseido Co Ltd 皮膚外用剤
US5571794A (en) 1995-06-22 1996-11-05 Frome; Bruce M. Non-invasive novel method fo cosmetic lip augmentation
JP3542665B2 (ja) 1995-07-07 2004-07-14 株式会社資生堂 抗老化皮膚外用剤、コラーゲン架橋阻害皮膚外用剤及び抗紫外線皮膚外用剤
DE69634404T2 (de) * 1995-08-14 2005-12-29 Optigenex, Inc. Caroteinoid-nicotinamid-zink zusammensetzungen und verfahren zur behandlung unter verwendung derselben
US5939082A (en) * 1995-11-06 1999-08-17 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
US6071888A (en) * 1996-01-24 2000-06-06 Aliatros Medical, A.S. Composition for treating cancer
US5736529A (en) * 1996-03-22 1998-04-07 Neurocal International Inc. Use of NAD-related compounds in the treatment of neural trauma to inhibit neurodegeneration
AUPN892496A0 (en) * 1996-03-25 1996-04-18 Technical Consultancy Services Pty Limited Acne treatment
US5693671A (en) * 1996-05-01 1997-12-02 Harbor-Ucla Research And Education Institute L-glutamine therapy for sickle cell diseases and thalassemia
EP1063963A1 (en) * 1998-03-16 2001-01-03 The Procter & Gamble Company Method of reducing cellulite in mammalian skin
US6277613B1 (en) 1998-06-10 2001-08-21 The Rockefeller University TRF1 binding protein, methods of use thereof
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
US5976513A (en) 1998-10-16 1999-11-02 The Procter & Gamble Company UV protection compositions
WO2000032179A2 (en) * 1998-12-01 2000-06-08 University Of Kentucky Research Foundation Use of nicotonic acid derivatives for the treatment of dna damage in skin cells

Also Published As

Publication number Publication date
US6337065B1 (en) 2002-01-08
WO2000032179A3 (en) 2001-12-13
US6552050B2 (en) 2003-04-22
CA2352964C (en) 2006-10-17
US7425319B2 (en) 2008-09-16
DK1143954T3 (da) 2004-12-20
US6403619B1 (en) 2002-06-11
EP1143954B1 (en) 2004-08-11
AU762770B2 (en) 2003-07-03
DE69919403D1 (de) 2004-09-16
ES2228146T3 (es) 2005-04-01
ATE273008T1 (de) 2004-08-15
NZ511708A (en) 2003-12-19
WO2000032179A2 (en) 2000-06-08
AU1929200A (en) 2000-06-19
CA2352964A1 (en) 2000-06-08
IL143112A0 (en) 2002-04-21
IL143112A (en) 2006-10-31
TWI257303B (en) 2006-07-01
DE69919403T2 (de) 2005-09-08
AR023715A1 (es) 2002-09-04
HK1041436A1 (en) 2002-07-12
US20040147491A1 (en) 2004-07-29
HK1041436B (zh) 2005-03-11
EP1143954A2 (en) 2001-10-17
US20010033848A1 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
PT1143954E (pt) Utilizacao de derivados de acido nocotinico para o tratamento de danos no adn em celulas da pele
BR0009158B1 (pt) composição tópica baseada em ácido ascórbico para o tratamento de danos na pele
EE200100480A (et) Ksenoon kasutamiseks närvimürgistuste ravis
ATE371457T1 (de) Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
PT1371647E (pt) Derivados do acido piridina-3-carboxilico e sua utilizacao como intermediarios
NO20003818D0 (no) FremgangsmÕte og innretning for behandling av kroppsvev med elektrisitet eller medikamenter
ID26725A (id) Zat untuk mencegah dan mengobati penyakit-penyakit kulit
BR9707425A (pt) Composto processo terapêutico para inibir o crescimento de células cancerosas e processo para utilizar o composto
BR9916450B1 (pt) mÉtodo cosmÉtico nço-terapÊutico para tratar e/ou prevenir condiÇÕes de pele e uso de Ácido linoleico conjugado e/ou derivados do mesmo.
DE60025641D1 (de) Haarbehandlungsmittel enthaltend partikuläre substanzen
PT948308E (pt) Metodos para o tratamento de pigmentacao da pele
IL141057A0 (en) Laser for skin treatment
DE60020820D1 (de) Thiadiazolyl-harnstoffe oder -thioharnstoffe zur antiviralen behandlung
DE60232400D1 (de) Mittel zur linderung von hautreizungen
MX215915B (es) Procedimiento para preparar sales de acido carboxilico y catalizadores utiles en dicho procedimiento.
PT1228032E (pt) Composicoes contendo derivados do acido hidroxieicosatetraenoico e metodos de utilizacao para o tratamento de desordens do olho seco
DE60008807D1 (de) Binaphtol-monophosphorsäurederivate und deren Verwendung
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
ID29792A (id) Formulasi lepas terkendali untuk mengobati corp
ATE276234T1 (de) Harnstoffderivate zur schmerzbekämpfung
DE60023003D1 (de) Haarbehandlungsmittel
ID30131A (id) Penggunaan zat penurun kolesterol
AU5327800A (en) Methods for treating skin with 3-hydroxy benzoic acid and related compositions
PT1097159E (pt) Utilizacao de derivados de acidos fosfinicos e fosfonicos como medicamentos
PL356127A1 (en) Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye